We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$548M
AUM Growth
-$89.4M
Cap. Flow
-$107M
Cap. Flow %
-19.59%
Top 10 Hldgs %
24.74%
Holding
348
New
22
Increased
127
Reduced
117
Closed
29

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$7.61M
2
EW icon
Edwards Lifesciences
EW
+$5.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$4.47M
4
DG icon
Dollar General
DG
+$4.1M
5
LPLA icon
LPL Financial
LPLA
+$3.22M

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$13.1M
2
MKTX icon
MarketAxess Holdings
MKTX
+$8.31M
3
NEM icon
Newmont
NEM
+$7.69M
4
LLY icon
Eli Lilly
LLY
+$6.64M
5
UTHR icon
United Therapeutics
UTHR
+$6.19M

Sector Composition

Rank Sector Weight
1 Healthcare 32.67%
2 Consumer Staples 19.07%
3 Technology 15.04%
4 Financials 9.84%
5 Communication Services 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADM icon
76
Archer Daniels Midland
ADM
$40.8B
$1.39M 0.25%
23,249
-33,466
-59% -$2.04M
UNH icon
77
UnitedHealth
UNH
$356B
$1.36M 0.25%
2,320
+429
+23% +$243K
TU icon
78
Telus
TU
$15.2B
$1.33M 0.24%
58,515
+47,909
+452% +$774K
PG icon
79
Procter & Gamble
PG
$340B
$1.3M 0.24%
7,487
+827
+12% +$140K
DDOG icon
80
Datadog
DDOG
$76.5B
$1.22M 0.22%
10,589
-4,104
-28% -$479K
IBM icon
81
IBM
IBM
$221B
$1.22M 0.22%
5,499
-6,317
-53% -$1.24M
KDP icon
82
Keurig Dr Pepper
KDP
$44.3B
$1.21M 0.22%
32,203
+30,090
+1,424% +$1.06M
V icon
83
Visa
V
$700B
$1.15M 0.21%
4,196
+452
+12% +$122K
FNV icon
84
Franco-Nevada
FNV
$51.3B
$1.14M 0.21%
6,800
-1,252
-16% -$155K
BCE icon
85
BCE
BCE
$22.1B
$1.14M 0.21%
24,155
+3,125
+15% +$107K
HPQ icon
86
HP
HPQ
$29.4B
$1.11M 0.2%
31,008
-6,860
-18% -$242K
WST icon
87
West Pharmaceutical
WST
$23.9B
$1.11M 0.2%
3,700
+2,423
+190% +$742K
ALL icon
88
Allstate
ALL
$65.6B
$1.09M 0.2%
5,750
+2,655
+86% +$472K
AMD icon
89
Advanced Micro Devices
AMD
$780B
$1.09M 0.2%
6,632
+641
+11% +$97.4K
GILD icon
90
Gilead Sciences
GILD
$187B
$1.09M 0.2%
12,962
+730
+6% +$55.7K
BIIB icon
91
Biogen
BIIB
$32.6B
$1.04M 0.19%
5,345
– –
CF icon
92
CF Industries
CF
$20.2B
$1.01M 0.18%
11,749
-249
-2% -$19.3K
REGN icon
93
Regeneron Pharmaceuticals
REGN
$85.2B
$992K 0.18%
944
-114
-11% -$127K
RCI icon
94
Rogers Communications
RCI
$20.3B
$935K 0.17%
17,192
+2,197
+15% +$86K
IBN icon
95
ICICI Bank
IBN
$109B
$912K 0.17%
30,544
+5,992
+24% +$174K
INCY icon
96
Incyte
INCY
$25.7B
$878K 0.16%
+13,276
New +$847K
P
97
Everpure Inc
P
$33.1B
$873K 0.16%
17,370
+16,214
+1,403% +$917K
KO icon
98
Coca-Cola
KO
$379B
$845K 0.15%
11,760
+541
+5% +$37K
ERIE icon
99
Erie Indemnity
ERIE
$13.2B
$839K 0.15%
1,555
-1,073
-41% -$488K
CCJ icon
100
Cameco
CCJ
$43.9B
$805K 0.15%
12,467
-9,353
-43% -$408K
2 3
4
5 6

Similar funds

EC
EntryPoint Capital New York $412M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return

TOBAM's Q3 2024 Portfolio in Review

As of Q3 2024, TOBAM held 348 positions worth $548M, down 14% from $638M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

TOBAM withdrew a net $107M in Q3 2024, closing 29 positions and reducing 117 holdings. Its most notable exit was Kellanova, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Incyte worth $878K.

  • TOBAM's largest Q3 2024 buy was Incyte: 13,276 shares worth $878K.
  • TOBAM added most to DexCom in Q3 2024, an estimated $7.61M increase.
  • TOBAM's biggest Q3 2024 reduction was Newmont, cutting an estimated $7.69M.
  • TOBAM fully exited Kellanova in Q3 2024, selling an estimated $13.1M.
  • TOBAM's ten largest holdings make up 25% of its $548M portfolio in Q3 2024.
  • TOBAM opened 22 new positions and closed 29 in Q3 2024.
  • TOBAM's portfolio value fell 14% quarter-over-quarter to $548M.

Based on TOBAM's 13F filing for Q3 2024, filed 9 Oct 2024.